Since 1923, we have been focused on innovation and leadership in diabetes care. Today we have a broad portfolio of medicines.
Since the launch of our first pen needle in 1985, we have been committed to enhancing injection experience by putting technology in patient hands.
Access information on our products for rare bleeding disorders, growth hormone-related disorders, and women's health.
Find information on our treatment for chronic weight management in adults who are overweight with one weight-related comorbidity or obesity.
The link above used in conjunction with the FDA-approved product labeling may be used to determine U.S. patents associated with the corresponding U.S. marketed product.
A place to find different points of view
from inside Novo Nordisk and the communities we serve.
We celebrate 11 consecutive years on the list.
Ashley and Daniel both have type 1 diabetes. They found love and understanding in each other.
We have information for furloughed workers and others who need help affording our medicines.
Novo Nordisk Obesity Patient Ambassadors cover the largest obesity conference in the world.
For more than half of the 30 years I’ve lived with type 1 diabetes, I depended on human insulin to effectively control my blood sugars.
Find inspiration in stories by people who knew it was their time to act.
A Novo Nordisk researcher shares his personal motivation for helping people with diabetes.
Watch the video
A photographer captures scenes of people living with diabetes around the world.
See the photos
I’ve personally struggled with weight, so I felt a little intimidated when I took on a role in obesity communications at Novo Nordisk.
Read the story
Congrats to Stacy Hintzman, Novo Nordisk 2018 Working Mother of the Year!
Stacy’s kids share a message about their mom